Status:
ENROLLING_BY_INVITATION
Evaluating the Feasibility and Preliminary Effects of BE+
Lead Sponsor:
University of South Carolina
Conditions:
Lung Cancer (Non-Small Cell)
Self-management Behavior
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
This non-randomized, single group study will test a 12-week, behavioral intervention for physical activity and stress management for survivors of non-small cell lung cancer (NSCLC) and a partner (fami...
Detailed Description
Lung cancer is the second-most diagnosed malignancy, accounting for more annual deaths than breast, prostate, and colorectal cancers combined. Approximately 80% of lung cancer diagnoses are non-small-...
Eligibility Criteria
Inclusion
- Survivors of NSCLC who have completed definitive treatment within the last 2 years.
- All participants must have a health clearance for physical activity signed by a healthcare provider; have Wi-Fi access; be able to provide informed consent; and be able to speak and read English.
Exclusion
- Survivors on current definitive treatment.
- All participants with a history of recurrent falls; a substantial mobility impairment related to chronic disease or injury; and lack of physical activity readiness as determined by a healthcare provider.
Key Trial Info
Start Date :
August 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07214441
Start Date
August 15 2025
End Date
May 1 2026
Last Update
October 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of South Carolina
Columbia, South Carolina, United States, 29208